244 related articles for article (PubMed ID: 22722772)
1. Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.
Manso Y; Carrasco J; Comes G; Meloni G; Adlard PA; Bush AI; Vašák M; Hidalgo J
Cell Mol Life Sci; 2012 Nov; 69(21):3683-700. PubMed ID: 22722772
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the role of the antioxidant proteins metallothioneins 1 and 2 in an animal model of Alzheimer's disease.
Manso Y; Carrasco J; Comes G; Adlard PA; Bush AI; Hidalgo J
Cell Mol Life Sci; 2012 Nov; 69(21):3665-81. PubMed ID: 22766972
[TBL] [Abstract][Full Text] [Related]
3. IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer's disease.
Escrig A; Canal C; Sanchis P; Fernández-Gayol O; Montilla A; Comes G; Molinero A; Giralt M; Giménez-Llort L; Becker-Pauly C; Rose-John S; Hidalgo J
Brain Behav Immun; 2019 Nov; 82():145-159. PubMed ID: 31401302
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.
Manso Y; Comes G; López-Ramos JC; Belfiore M; Molinero A; Giralt M; Carrasco J; Adlard PA; Bush AI; Delgado-García JM; Hidalgo J
J Alzheimers Dis; 2016; 51(1):81-95. PubMed ID: 26836194
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Mint proteins decreases amyloid production in transgenic mouse models of Alzheimer's disease.
Ho A; Liu X; Südhof TC
J Neurosci; 2008 Dec; 28(53):14392-400. PubMed ID: 19118172
[TBL] [Abstract][Full Text] [Related]
7. β‑asarone modulates Beclin‑1, LC3 and p62 expression to attenuate Aβ40 and Aβ42 levels in APP/PS1 transgenic mice with Alzheimer's disease.
Deng M; Huang L; Zhong X
Mol Med Rep; 2020 May; 21(5):2095-2102. PubMed ID: 32186763
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
9. Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice.
Araki W; Oda A; Motoki K; Hattori K; Itoh M; Yuasa S; Konishi Y; Shin RW; Tamaoka A; Ogino K
Curr Alzheimer Res; 2013 Feb; 10(2):135-42. PubMed ID: 22742855
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice.
Wang J; Tanila H; Puoliväli J; Kadish I; van Groen T
Neurobiol Dis; 2003 Dec; 14(3):318-27. PubMed ID: 14678749
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
[TBL] [Abstract][Full Text] [Related]
13. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
[TBL] [Abstract][Full Text] [Related]
14. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
[TBL] [Abstract][Full Text] [Related]
15. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
16. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.
Wang C; Sun B; Zhou Y; Grubb A; Gan L
J Biol Chem; 2012 Nov; 287(47):39834-41. PubMed ID: 23024364
[TBL] [Abstract][Full Text] [Related]
19. Influence of Transgenic Metallothionein-1 on Gliosis, CA1 Neuronal Loss, and Brain Metal Levels of the Tg2576 Mouse Model of Alzheimer's Disease.
Comes G; Manso Y; Escrig A; Fernandez-Gayol O; Sanchis P; Molinero A; Giralt M; Carrasco J; Hidalgo J
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134760
[TBL] [Abstract][Full Text] [Related]
20. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
